COMP <GO>
LNTH vs IDXX // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Lantheus Holdings Inc. (NASDAQ) VS. IDEXX Laboratories Inc. (NASDAQ) • 15-METRIC TALLY: LNTH 4
— IDXX 9
■ METRIC PARITY
LAST: $100.31 (-0.15%) • MKT CAP: $6.56B
options-implied-move
—
LAST: $671.64 (+21.85%) • MKT CAP: $43.42B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNTH VS. IDXX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LNTH | IDXX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.10% | 61.80% | -0.70 | IDXX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.30% | 29.60% | -9.30 | IDXX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.0x | 31.1x | -13.10 | LNTH | /valuation <GO> |
| Free Cash Flow Yield | 4.90% | 2.33% | +2.57 | LNTH | /fcf-yield <GO> |
| Operating Margin | 20.20% | 31.60% | -11.40 | IDXX | /operating-margins <GO> |
| Net Profit Margin | 15.20% | 24.60% | -9.40 | IDXX | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | 10.40% | -9.90 | IDXX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.34 | 20.99 | -15.65 | IDXX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | IDXX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.8 | 50.5 | +5.30 | LNTH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.89 | -0.01 | IDXX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.0x | 39.8x | -13.80 | LNTH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.56B | $43.42B | -$36.87B | IDXX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LNTH REV | IDXX REV | LNTH GROSS % | IDXX GROSS % | LNTH FCF | IDXX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.54B | $4.30B | 61.1% | 61.8% | $320.8M | $1.06B |
| FY 2024 | $1.53B | $3.90B | 64.4% | 61.0% | $475.7M | $808.1M |
| FY 2023 | $1.30B | $3.66B | — | — | $246.9M | $741.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNTH // BETA 0.88
IDXX // BETA 0.89